Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma (Q64714612)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
clinical trial

    Statements

    REGAL (English)
    0 references
    A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    October 2008
    0 references
    April 2010
    0 references
    423
    0 references
    18 year
    0 references
    100 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit